RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xuebiao Yao to Carcinoma, Pancreatic Ductal

Back to Details
This is a "connection" page, showing publications Xuebiao Yao has written about Carcinoma, Pancreatic Ductal.
Xuebiao Yao
Connection Strength
0.284
Carcinoma, Pancreatic Ductal
  1. Fang C, Guo X, Lv X, Yin R, Lv X, Wang F, Zhao J, Bai Q, Yao X, Chen Y. Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K. J Mol Cell Biol. 2017 12 01; 9(6):504-515.
    View in: PubMed
    Score: 0.149
  2. Guo X, Lv X, Fang C, Lv X, Wang F, Wang D, Zhao J, Ma Y, Xue Y, Bai Q, Yao X, Chen Y. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. Int J Cancer. 2016 10 15; 139(8):1821-9.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support